An interventional study of Arthrex Tightrope and Synthes Fibulink in Syndesmotic Injuries, sponsored by United States Naval Medical Center, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-06.
Sponsored by United States Naval Medical Center, San Diego · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 83 studies in Ankle Injuries with a site in United States — 16 open to participants now, 18 under way, none of them phase 3. Ankle Injuries · United States.
Among the 83 studies in Ankle Injuries with a site in United States, this one is the 33rd largest by planned enrollment of the 71 interventional ones that give a count, is one of 8 that started in 2022, is one of 54 with no phase, reaches primary completion later than 0 of the 17 other live ones, and was the 62nd registered.
354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.
Browse Ankle Injuries studies →16 of the 83 studies in Ankle Injuries with a site in United States are open now. Recruiting first, the newest first:
University of Wisconsin, Madison · Sites in United States
Ages 18–40 · Healthy volunteers
Hancock Orthopedics · Sites in United States
Ages 18+
University of California, San Diego · Sites in United States
Ages 13–18
Danielle Torp · Sites in United States
Ages 18–45 · Healthy volunteers
University of Colorado, Denver · Sites in United States
Ages 18–70
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
83 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 10 · Phase 4 2
First in 2006; this study’s year is marked. 8 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is close to the median of 54 across 274 interventional studies indexed under Ankle Injuries.
Median enrollment 50 across the 71 interventional studies, 60 across the 12 observational. Of the 54 that completed or were terminated, 15 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 83 have an industry lead sponsor. The 10 most frequent:
United States Naval Medical Center, San Diego is the lead sponsor of 65 studies on the registry; 6 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
United States Naval Medical Center, San Diego has 1 study filed under Ankle Injuries — fewer than ten, so there is no comparison to draw.
9 of the studies in Ankle Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04493645Matthew HochAnkle Instability Using Foot Intensive Rehabilitation | 2026-12-01 |
| NCT07025733University of Colorado, DenverSemiconductor Embedded Socks for Ankle Sprains | 2026-12-31 |
| NCT06085586Maimonides Medical CenterFibulink Syndesmosis Repair System With Early Full-Weight Bearing | 2026-12-31 |
| NCT05729542University of California, San DiegoComparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries | 2026-12-31 |
| NCT06719609University of Wisconsin, MadisonEnovis High Ankle Sprain Brace Testing | 2027-05 |
Add all 9 to your calendar (.ics) → With an account.
Among the 83 studies in Ankle Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ankle fractures are a common injury with potentially significant morbidity. Syndesmosis injury occurs in 10% to 13% of ankle fractures and poses a greater risk to long-term outcomes for patients.
The gold standard for syndesmosis fixation has traditionally been screw fixation. However, issues with screw fixation include screw breakage, screw loosening, reoperation, and malreduction. Due to growing concerns with static screw fixation, implants based on the flexible suture button design, such as the TightRope system, gained traction.
The Fibulink Syndesmosis Repair System, a relatively new design that became clinically available in 2017, has showed promising results.
To our knowledge, there is no study that directly compares outcomes with the Fibulink implant to suture button implants.
Ankle fractures are a common injury with potentially significant morbidity. Syndesmosis injury occurs in 10% to 13% of ankle fractures and poses a greater risk to long-term outcomes for patients1,2. If not recognized and adequately reduced, injuries to the syndesmosis have shown to result in instability, persistent pain, and post-traumatic arthritis3. 11% of cases are accompanied by symptomatic advanced osteoarthritis after fixation of the syndesmosis4.
The gold standard for syndesmosis fixation has traditionally been screw fixation5. However, issues with screw fixation include screw breakage, screw loosening, reoperation, and malreduction6-8. This has been speculated to be a result of the ankle syndesmosis, a dynamic construct, being inappropriately fixed with static fixation. Due to growing concerns with static screw fixation, implants based on the flexible suture button design, such as the TightRope system, gained traction. Advantages with these designs include superior outcome scores, as well as lower rates of osteoarthritis and reoperation7,9,10. However, despite achieving improved joint mechanics, these systems have their drawbacks as well, such as infection or damage to the superficial medial neurovascular bundle9.
The Fibulink Syndesmosis Repair System, a relatively new design that became clinically available in 2017, has showed promising results. It has been promoted as an implant that potentially provides both the fixation of a screw and flexibility of a suture to respect the dynamic nature of the ankle joint. Benefits of this design include eliminating damage to the medial neurovascular bundle and soft tissues, promoting physiologic motion of the ankle joint, and allowing improved tension control. In a case series with 14 patients that received the Fibulink implant, Desai found no complications with a mean follow-up of 9.5 months9. However, more long-term data is needed in order to draw any conclusions. The potential advantage of this system over suture button designs is that it incorporates the rigidity of screw fixation on top of the dynamic fixation of suture button implants. It also addresses the limitations of suture button designs, such as avoiding medial soft tissue disruption and lack of two-way tension control.
The comparison between screw fixation and suture button designs has been thoroughly investigated in the literature. To our knowledge, there is no study that directly compares outcomes with the Fibulink implant to suture button implants. It is imperative to directly compare these methods so we can definitively assess their suitability and provide patients that sustain these injuries the best method of fixation in order to improve patient outcomes.
The purpose of this study is to compare radiographic and clinical outcomes in patients who sustain an acute ankle fracture with an associated syndesmosis injury by comparing two surgical treatments currently in the practice of the study investigators. The study will compare suture button fixation versus Fibulink implant in patients with this injury.
Inadequate syndesmosis fixation has been found to result in significant morbidity to patients, including persistent pain, instability, and post-traumatic arthritis. This emphasizes the need to assess the available methods of fixation in order to minimize negative long-term consequences. Currently, standard single screw fixation remains a common choice among orthopaedic surgeons. However, there is some evidence of superior outcomes with dynamic fixation, using designs such as the suture button or the Fibulink system, in terms of functional results, residual pain, and other measures. With an enhanced understanding of patient outcomes with these methods of fixation, we will better be able to determine more effective ways to manage these injures and offer guidance for optimal management and patient satisfaction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Syndesmosis fixation performed with Arthrex Tightrope device. This is a high-tension suture fixation with a button based anchor system.
Device: Arthrex Tightrope
Syndesmosis fixation performed with Synthes Fibulink device. This is a high-tension suture fixation with a screw based anchor system.
Device: Synthes Fibulink
High-tensile strength suture syndesmosis repair
High-tensile strength suture syndesmosis repair
Visual Analog Scale (VAS) pain score
VAS pain score is rated from 0-10 with 0 being no pain and 10 being the worst pain possible.
Time frame: 1 year
Foot and Ankle Disability Index
Functional score with a score of 0-104 with higher scores indicating better function.
Time frame: 1 year
Olerud-Molander Ankle Score
Functional score with a score of 0-100 with higher scores indicating better function
Time frame: 1 year
Number of participants with medical or surgical complications
Medical and surgical complications to include: surgical site infection, re-operation, device failure, loss of motion
Time frame: 1 year
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Dec 2022 (actual). Primary completion is estimated for Dec 2024, 24 months after the start.
Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 24 months is above that.
Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
United States Naval Medical Center, San Diego